AN2 Therapeutics, Inc.
ANTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $21 | $16 | $27 | $12 |
| Short-Term Investments | $62 | $92 | $69 | $46 |
| Receivables | $0 | $1 | $0 | $0 |
| Inventory | $0 | $0 | $0 | $0 |
| Other Curr. Assets | $2 | $2 | $3 | $2 |
| Total Curr. Assets | $86 | $111 | $99 | $60 |
| Property Plant & Equip (Net) | $0 | $0 | $0 | $0 |
| Goodwill | $0 | $0 | $0 | $0 |
| Intangibles | $0 | $0 | $0 | $0 |
| Long-Term Investments | $5 | $27 | $3 | $3 |
| Tax Assets | $0 | $0 | $0 | $0 |
| Other NC Assets | $1 | $1 | $1 | $2 |
| Total NC Assets | $6 | $28 | $4 | $5 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $92 | $139 | $103 | $65 |
| Liabilities | – | – | – | – |
| Payables | $3 | $3 | $2 | $1 |
| Short-Term Debt | $0 | $0 | $0 | $0 |
| Tax Payable | $0 | $0 | $0 | $0 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $7 | $11 | $5 | $2 |
| Total Curr. Liab. | $10 | $14 | $7 | $3 |
| LT Debt | $0 | $0 | $0 | $0 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $0 | $0 |
| Other NC Liab. | $0 | $0 | $0 | $0 |
| Total NC Liab. | $0 | $0 | $0 | $0 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $0 | $0 | $0 | $0 |
| Total Liabilities | $10 | $14 | $7 | $3 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $109 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | -$206 | -$154 | -$90 | -$47 |
| AOCI | $0 | $0 | -$0 | -$0 |
| Other Equity | $288 | $279 | $185 | $0 |
| Total Equity | $82 | $125 | $95 | $62 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $92 | $139 | $103 | $65 |
| Net Debt | -$21 | -$16 | -$27 | -$12 |